Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2020 & Forecast to 2028 - ResearchAndMarkets.com

The "Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

The extra corporeal membrane oxygenation (ECMO) system market in Latin America is set to bloom at a CAGR of 4.55% in the forthcoming years (2019-2028).

Brazil, Mexico and Rest of Latin America compromise the extra corporeal membrane oxygenation (ECMO) system market in Latin America.

As per the WHO (World Health Organization), in Mexico, about 85,961 deaths were caused by ischemic heart disease in 2015. This can be majorly reduced with the use of extracorporeal membrane oxygenation. The CESAR trial compared conventional ventilation methods and extracorporeal membrane oxygenation in the treatment of acute respiratory failure. This prompted the initiation of the ECMO program Mexico in May 2010, which is contributing to the increased adoption of ECMO systems in the country. In 2017, Mexico also demonstrated the first successful sequential bilateral lung transplant with the use of ECMO systems in the world. Such factors are indicating an increased market growth of ECMO systems in the country.

It is reported that in Brazil, the extra corporeal membrane oxygenation (ECMO) is a leading extra corporeal life support device, which is used in critically ill patients with pulmonary and cardiac failure. Venovenous-ECMO is also used as a support at times of respiratory failure. These factors are estimated to aid the studied market growth.

COMPETITIVE OUTLOOK

Some of the major players in the extra corporeal membrane oxygenation (ECMO) system market are ALung Technologies Inc, Terumo Medical Corporation, Elsius Biomedical Inc, Hemovent Gmbh, Eurosets, LivaNova Plc and Getinge AB.

Key Topics Covered:

Table of Contents

1. Latin America Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Summary

2. Industry Outlook

2.1.Market Definition

2.2.Porter's Five Forces Model

2.3.Impact of Covid-19 on ECMO System Market

2.4.Market Attractiveness Index

2.5.Vendor Scorecard

2.6.Key Insights

2.7.Market Drivers

2.7.1.Rising Popularity of ECMO Technology

2.7.2.Increasing Prevalence of Chronic Disorders

2.8.Market Restraints

2.8.1.Significant Cost of ECMO Systems

2.8.2.Existence of Alternative Techniques

2.9.Market Opportunities

2.9.1.Growing Awareness Regarding Applications of ECMO Systems

2.9.2.Advancement in Technology

2.10.Market Challenges

2.10.1.Lack of Specialized Skills for Operation

2.10.2.Risks Associated With ECMO Procedures

3. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Application

3.1.Respiratory

3.2.Cardiac

3.3.Extracorporeal Cardiopulmonary Resuscitation (Ecpr)

4. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Modality

4.1.Veno-Venous

4.2.Veno-Arterial

4.3.Other Modalities

5. Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Latin America

5.1.Brazil

5.2.Mexico

5.3.Rest of Latin America

6. Company Profiles

6.1.Hemovent GmbH

6.2.Livanova plc

6.3.Microport Scientific Corporation

6.4.Terumo Medical Corporation

6.5.Elsius Biomedical Inc

6.6.Abbott Laboratories

6.7.Alung Technologies Inc

6.8.Eurosets

6.9.Spectrum Medical

6.10.Xenios AG (Fresenius SE & Co KGAA)

6.11.Medtronic plc

6.12.Getinge Ab

6.13.Nipro Corporation

6.14.Origen Biomedical Inc

7. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/t1735y

View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005729/en/